INCOME STATEMENT
Remus Pharmaceuticals Ltd.
NSE
Jun 06, 03:31
1971.65
-18.70 ( -0.94%)
Volume
1050
Prev. Close
1990.35
Open Price
1985.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE0O5T01011
|
Market Cap. ( ₹ in Cr. )
|
1161.70
|
P/BV
|
11.56
|
Book Value ( ₹ )
|
170.55
|
|
BSE Code
|
-
|
52 Week High/Low ( ₹ )
|
2835/1675
|
FV/ML
|
10/50
|
P/E(X)
|
39.96
|
|
NSE Code
|
REMUSSM
|
Book Closure
|
20/11/2024
|
EPS ( ₹ )
|
49.34
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 79.16 | 63.50 | 45.03 | 24.72 | 18.42 |
| Total Operating Revenues | 79.16 | 63.50 | 45.03 | 24.72 | 18.42 |
| | | | | | |
| Other Income | 2.91 | 3.69 | 1.58 | 0.72 | 0.81 |
| Total Revenue | 82.07 | 67.19 | 46.60 | 25.44 | 19.22 |
| | | | | | |
| EXPENSES | | | | | |
| Purchase Of Stock-In Trade | 35.27 | 29.21 | 20.14 | 12.71 | 12.21 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.23 | -1.38 | 1.30 | -0.44 | -0.71 |
| Employee Benefit Expenses | 9.17 | 6.56 | 5.47 | 3.49 | 3.00 |
| Finance Costs | 0.38 | 0.32 | 0.23 | 0.09 | 0.04 |
| Depreciation And Amortisation Expenses | 1.87 | 0.90 | 0.48 | 0.15 | 0.18 |
| Other Expenses | 8.97 | 9.06 | 7.57 | 4.89 | 3.17 |
| Total Expenses | 55.43 | 44.67 | 35.19 | 20.89 | 17.87 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 26.64 | 22.52 | 11.41 | 4.55 | 1.36 |
| | | | | | |
| Profit/Loss Before Tax | 26.64 | 22.52 | 11.41 | 4.55 | 1.36 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 6.74 | 6.45 | 3.00 | 1.19 | 0.37 |
| Deferred Tax | 0.00 | -0.71 | -0.09 | -0.03 | -0.03 |
| Tax For Earlier Years | 0.00 | -0.03 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | 6.74 | 5.71 | 2.91 | 1.16 | 0.33 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 19.90 | 16.82 | 8.50 | 3.39 | 1.03 |
| | | | | | |
| Profit/Loss From Continuing Operations | 19.90 | 16.82 | 8.50 | 3.39 | 1.03 |
| | | | | | |
| Profit/Loss For The Period | 19.90 | 16.82 | 8.50 | 3.39 | 1.03 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 33.75 | 118.72 | 83.24 | 33.86 | 10.26 |
| Diluted EPS (Rs.) | 33.75 | 118.72 | 83.24 | 33.86 | 10.26 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.59 | 0.00 | 0.00 | 0.00 |
| Equity Dividend Rate (%) | 10.00 | 60.00 | 20.00 | 0.00 | 0.00 |